Annual Shareholders Equity
$8.39 M
+$5.29 M+170.70%
December 31, 2023
Summary
- As of February 8, 2025, ABVC annual stockholders equity is $8.39 million, with the most recent change of +$5.29 million (+170.70%) on December 31, 2023.
- During the last 3 years, ABVC annual shareholders equity has risen by +$4.95 million (+143.96%).
- ABVC annual shareholders equity is now -5.15% below its all-time high of $8.84 million, reached on December 31, 2021.
Performance
ABVC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$8.36 M
+$65.00 K+0.78%
September 30, 2024
Summary
- As of February 8, 2025, ABVC quarterly stockholders equity is $8.36 million, with the most recent change of +$65.00 thousand (+0.78%) on September 30, 2024.
- Over the past year, ABVC quarterly shareholders equity has dropped by -$741.40 thousand (-8.15%).
- ABVC quarterly shareholders equity is now -10.45% below its all-time high of $9.33 million, reached on June 30, 2022.
Performance
ABVC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ABVC Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +170.7% | -8.2% |
| 3 y3 years | +144.0% | -2.7% |
| 5 y5 years | +245.9% | -2.7% |
ABVC Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.2% | +170.7% | -10.4% | +2303.7% |
| 5 y | 5-year | -5.2% | +5655.0% | -10.4% | +835.3% |
| alltime | all time | -5.2% | +231.5% | -10.4% | +228.2% |
ABVC BioPharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.36 M(+0.8%) |
| Jun 2024 | - | $8.29 M(+6.4%) |
| Mar 2024 | - | $7.79 M(-7.1%) |
| Dec 2023 | $8.39 M(+170.7%) | $8.39 M(-7.8%) |
| Sep 2023 | - | $9.10 M(-2499.1%) |
| Jun 2023 | - | -$379.30 K(-122.7%) |
| Mar 2023 | - | $1.67 M(-46.1%) |
| Dec 2022 | $3.10 M(-65.0%) | $3.10 M(-47.6%) |
| Sep 2022 | - | $5.92 M(-36.6%) |
| Jun 2022 | - | $9.33 M(+25.7%) |
| Mar 2022 | - | $7.43 M(-16.0%) |
| Dec 2021 | $8.84 M(+157.2%) | $8.84 M(+2.9%) |
| Sep 2021 | - | $8.59 M(+496.6%) |
| Jun 2021 | - | $1.44 M(-44.0%) |
| Mar 2021 | - | $2.57 M(-25.2%) |
| Dec 2020 | $3.44 M(-2377.0%) | $3.44 M(-741.0%) |
| Sep 2020 | - | -$536.40 K(-50.0%) |
| Jun 2020 | - | -$1.07 M(-5.5%) |
| Mar 2020 | - | -$1.14 M(+652.8%) |
| Dec 2019 | -$151.00 K(-97.4%) | -$151.00 K(-122.7%) |
| Sep 2019 | - | $665.90 K(-120.1%) |
| Jun 2019 | - | -$3.32 M(-42.4%) |
| Mar 2019 | - | -$5.76 M(+0.2%) |
| Dec 2018 | -$5.75 M(+227.2%) | -$5.75 M(+134.8%) |
| Sep 2018 | - | -$2.45 M(+9.4%) |
| Jun 2018 | - | -$2.24 M(+15.7%) |
| Mar 2018 | - | -$1.93 M(+10.0%) |
| Dec 2017 | -$1.76 M(+26.1%) | -$1.76 M(+26.1%) |
| Sep 2017 | - | -$1.39 M(+32.9%) |
| Sep 2017 | -$1.39 M(-78.2%) | - |
| Jun 2017 | - | -$1.05 M(+13.6%) |
| Mar 2017 | - | -$922.70 K(-85.8%) |
| Dec 2016 | - | -$6.52 M(+2.2%) |
| Sep 2016 | -$6.38 M(-1107.1%) | -$6.38 M(-517.7%) |
| Jun 2016 | - | $1.53 M(+75.4%) |
| Mar 2016 | - | $870.70 K(+1241.6%) |
| Dec 2015 | - | $64.90 K(-89.8%) |
| Sep 2015 | $633.40 K(+1917.2%) | $633.40 K(+2018.4%) |
| Jun 2015 | - | $29.90 K(+4.2%) |
| Mar 2015 | - | $28.70 K(-2.7%) |
| Dec 2014 | - | $29.50 K(-6.1%) |
| Sep 2014 | $31.40 K | $31.40 K(-101.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | -$1.88 M(0.0%) |
| Mar 2014 | - | -$1.88 M(0.0%) |
| Dec 2013 | - | -$1.88 M(0.0%) |
| Sep 2013 | -$1.88 M(+14.4%) | -$1.88 M(0.0%) |
| Jun 2013 | - | -$1.88 M(+2.1%) |
| Mar 2013 | - | -$1.84 M(+2.2%) |
| Dec 2012 | - | -$1.80 M(+9.6%) |
| Sep 2012 | -$1.64 M(+12.3%) | -$1.64 M(+13.4%) |
| Jun 2012 | - | -$1.45 M(+4.7%) |
| Mar 2012 | - | -$1.38 M(+2.6%) |
| Dec 2011 | - | -$1.35 M(-7.8%) |
| Sep 2011 | -$1.46 M(-51.1%) | -$1.46 M(+7.2%) |
| Jun 2011 | - | -$1.37 M(-4.5%) |
| Mar 2011 | - | -$1.43 M(-55.1%) |
| Dec 2010 | - | -$3.18 M(+6.4%) |
| Sep 2010 | -$2.99 M(+48.9%) | -$2.99 M(+13.5%) |
| Jun 2010 | - | -$2.64 M(+2.9%) |
| Mar 2010 | - | -$2.56 M(+16.4%) |
| Dec 2009 | - | -$2.20 M(+9.4%) |
| Sep 2009 | -$2.01 M(+62.2%) | -$2.01 M(+1.8%) |
| Jun 2009 | - | -$1.98 M(-1.9%) |
| Mar 2009 | - | -$2.01 M(+4.1%) |
| Dec 2008 | - | -$1.93 M(+56.0%) |
| Sep 2008 | -$1.24 M(-527.1%) | -$1.24 M(-47.5%) |
| Jun 2008 | - | -$2.36 M(+117.4%) |
| Mar 2008 | - | -$1.09 M(+69.9%) |
| Dec 2007 | - | -$639.50 K(-5759.3%) |
| Sep 2007 | $290.30 K(+722.4%) | - |
| Jun 2007 | - | $11.30 K(-52.7%) |
| Mar 2007 | - | $23.90 K(-32.3%) |
| Dec 2006 | $35.30 K(-41.8%) | $35.30 K(-20.7%) |
| Sep 2006 | - | $44.50 K(-2.2%) |
| Jun 2006 | - | $45.50 K(-13.7%) |
| Mar 2006 | - | $52.70 K(-13.2%) |
| Dec 2005 | $60.70 K(-30.5%) | $60.70 K(-11.3%) |
| Sep 2005 | - | $68.40 K(-8.4%) |
| Jun 2005 | - | $74.70 K(-4.8%) |
| Mar 2005 | - | $78.50 K(-10.1%) |
| Dec 2004 | $87.30 K(+2.9%) | $87.30 K(-6.9%) |
| Sep 2004 | - | $93.80 K(+28.8%) |
| Jun 2004 | - | $72.80 K(-9.0%) |
| Mar 2004 | - | $80.00 K |
| Dec 2003 | $84.80 K | - |
FAQ
- What is ABVC BioPharma annual stockholders equity?
- What is the all time high annual shareholders equity for ABVC BioPharma?
- What is ABVC BioPharma annual shareholders equity year-on-year change?
- What is ABVC BioPharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ABVC BioPharma?
- What is ABVC BioPharma quarterly shareholders equity year-on-year change?
What is ABVC BioPharma annual stockholders equity?
The current annual shareholders equity of ABVC is $8.39 M
What is the all time high annual shareholders equity for ABVC BioPharma?
ABVC BioPharma all-time high annual stockholders equity is $8.84 M
What is ABVC BioPharma annual shareholders equity year-on-year change?
Over the past year, ABVC annual stockholders equity has changed by +$5.29 M (+170.70%)
What is ABVC BioPharma quarterly stockholders equity?
The current quarterly shareholders equity of ABVC is $8.36 M
What is the all time high quarterly shareholders equity for ABVC BioPharma?
ABVC BioPharma all-time high quarterly stockholders equity is $9.33 M
What is ABVC BioPharma quarterly shareholders equity year-on-year change?
Over the past year, ABVC quarterly stockholders equity has changed by -$741.40 K (-8.15%)